Clinical Trial Update: 24-hr IOP With Travoprost/Timolol Compared With Latanoprost/Timolol in XFG [Phase 4]

View source ↗

Summary

Phase 4 trial update comparing 24-hour intraocular pressure with travoprost/timolol versus latanoprost/timolol in glaucoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma

Drugs mentioned

• Travoprost/Timolol (travoprost/timolol)
• latanoprost/timolol

Snippet

Sponsor: Aristotle University Of Thessaloniki | Conditions: Glaucoma | Phase 4 | Status: COMPLETED